Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A real-world, observational study of erenumab for migraine prevention in Canadian patients.
Headache. 2022 Apr;62(4):522-529. doi: 10.1111/head.14291. Epub 2022 Apr 10.
Headache. 2022.
PMID: 35403223
Free PMC article.
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study.
Gladstone J, Chhibber S, Minhas J, Neish CS, Power GS, Lan Z, Rochdi D, Lanthier-Martel J, Bastien N.
Gladstone J, et al. Among authors: rochdi d.
Headache. 2022 Jan;62(1):78-88. doi: 10.1111/head.14218. Epub 2021 Nov 22.
Headache. 2022.
PMID: 34807454
Free PMC article.
Item in Clipboard
Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study.
Haddad H, Bergeron S, Ignaszewski A, Searles G, Rochdi D, Dhage P, Bastien N.
Haddad H, et al. Among authors: rochdi d.
CJC Open. 2020 Apr 26;2(5):344-353. doi: 10.1016/j.cjco.2020.04.007. eCollection 2020 Sep.
CJC Open. 2020.
PMID: 32995719
Free PMC article.
Item in Clipboard
The Burden of Illness of Migraine in Canada: New Insights on Humanistic and Economic Cost.
Amoozegar F, Khan Z, Oviedo-Ovando M, Sauriol S, Rochdi D.
Amoozegar F, et al. Among authors: rochdi d.
Can J Neurol Sci. 2022 Mar;49(2):249-262. doi: 10.1017/cjn.2021.75. Epub 2021 Apr 20.
Can J Neurol Sci. 2022.
PMID: 33875042
Item in Clipboard
Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study.
Kaplan A, Chapman KR, Anees SM, Mayers I, Rochdi D, Djandji M, Préfontaine D, McIvor A.
Kaplan A, et al. Among authors: rochdi d.
Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:249-260. doi: 10.2147/COPD.S185485. eCollection 2019.
Int J Chron Obstruct Pulmon Dis. 2019.
PMID: 30718952
Free PMC article.
Clinical Trial.
Item in Clipboard
Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD.
Carpentier E, Greenbaum LA, Rochdi D, Abrol R, Goddard WA 3rd, Bichet DG, Bouvier M.
Carpentier E, et al. Among authors: rochdi d.
J Am Soc Nephrol. 2012 Oct;23(10):1635-40. doi: 10.1681/ASN.2012010077. Epub 2012 Sep 6.
J Am Soc Nephrol. 2012.
PMID: 22956819
Free PMC article.
Item in Clipboard
Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
Bockenhauer D, Carpentier E, Rochdi D, van't Hoff W, Breton B, Bernier V, Bouvier M, Bichet DG.
Bockenhauer D, et al. Among authors: rochdi d.
Nephron Physiol. 2010;114(1):p1-10. doi: 10.1159/000245059. Epub 2009 Oct 8.
Nephron Physiol. 2010.
PMID: 19816050
Item in Clipboard
Cite
Cite